These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37293588)

  • 1. Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey.
    Mraz KA; Hodan R; Rodgers-Fouche L; Arora S; Balaguer F; Guillem JG; Jeter JM; Kanth P; Li D; Liska D; Melson J; Perez K; Ricker C; Shirts BH; Vilar E; Katona BW; Dominguez-Valentin M
    Front Oncol; 2023; 13():1141810. PubMed ID: 37293588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
    Burn J; Mathers J; Bishop DT
    Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial adenomatous polyposis.
    Half E; Bercovich D; Rozen P
    Orphanet J Rare Dis; 2009 Oct; 4():22. PubMed ID: 19822006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention in familial adenomatous polyposis: past, present and future.
    Kemp Bohan PM; Mankaney G; Vreeland TJ; Chick RC; Hale DF; Cindass JL; Hickerson AT; Ensley DC; Sohn V; Clifton GT; Peoples GE; Burke CA
    Fam Cancer; 2021 Jan; 20(1):23-33. PubMed ID: 32507936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan.
    Yamano T; Hamanaka M; Babaya A; Kimura K; Kobayashi M; Fukumoto M; Tsukamoto K; Noda M; Matsubara N; Tomita N; Sugihara K
    Cancer Sci; 2017 Feb; 108(2):243-249. PubMed ID: 27870147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
    Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental Finding of Attenuated Familial Adenomatous Polyposis.
    Bhesania S; Chelikam N; Mobin N; Ilyas S; Nimkar N
    Cureus; 2021 Sep; 13(9):e18237. PubMed ID: 34722036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome.
    Stone JK; Mehta NA; Singh H; El-Matary W; Bernstein CN
    Fam Cancer; 2023 Oct; 22(4):413-422. PubMed ID: 37119510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome.
    Barrow P; Khan M; Lalloo F; Evans DG; Hill J
    Br J Surg; 2013 Dec; 100(13):1719-31. PubMed ID: 24227356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in chemoprevention research for hereditary gastrointestinal and polyposis syndromes.
    Hall MJ
    Curr Treat Options Gastroenterol; 2021 Mar; 19(1):30-46. PubMed ID: 34211259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Surgical Concepts in Lynch Syndrome and Familial Adenomatous Polyposis.
    Horisberger K; Mann C; Lang H
    Visc Med; 2023 Mar; 39(1):1-9. PubMed ID: 37009233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and Pathological Features of Gastric Cancer in Lynch Syndrome and Familial Adenomatous Polyposis.
    Fornasarig M; Magris R; De Re V; Bidoli E; Canzonieri V; Maiero S; Viel A; Cannizzaro R
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of Precancers and Opportunities for Cancer Interception: Lesson from Colorectal Cancer Susceptibility Syndromes.
    Monahan KJ; Swinyard O; Latchford A
    Cancer Prev Res (Phila); 2023 Aug; 16(8):421-427. PubMed ID: 37001883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
    Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
    Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance recommendations for patients with Lynch syndrome and FAP : a monocentric study.
    Baert L; Claes K; De Man M; Tate DJ; Geboes K
    Acta Gastroenterol Belg; 2020; 83(3):399-405. PubMed ID: 33094586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted next-generation sequencing approach for molecular genetic diagnosis of hereditary colorectal cancer: Identification of a novel single nucleotide germline insertion in adenomatous polyposis coli gene causes familial adenomatous polyposis.
    Wang D; Liang S; Zhang X; Dey SK; Li Y; Xu C; Yu Y; Li M; Zhao G; Zhang Z
    Mol Genet Genomic Med; 2019 Jan; 7(1):e00505. PubMed ID: 30523670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pathogenic splice acceptor site germline mutation in intron 14 of the APC gene in a Chinese family with familial adenomatous polyposis.
    Wang D; Liang S; Zhang Z; Zhao G; Hu Y; Liang S; Zhang X; Banerjee S
    Oncotarget; 2017 Mar; 8(13):21327-21335. PubMed ID: 28423518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention in hereditary digestive neoplasia: A comprehensive review.
    Chevalier E; Benamouzig R
    Therap Adv Gastroenterol; 2023; 16():17562848231215585. PubMed ID: 38050626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.